BioSpace News Archive

Approval strengthens supply chain and reduces manufacturing costs for consumable component used with Viveves Cryogen-cooled Monopolar Radiofrequency technology

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced it was named the “Best Contract Research Organization” in the Full-Service Provider category at the Digital 16 th Annual Scrip Awards. The award was presented at the virtual awards ceremony Dec. 2. “This award belongs to our exceptionally talente

As education systems grapple with teaching during the pandemic, CIC Health uses the ixlayer COVID-19 Clinical Testing Platform to enable routine testing

Natera, Inc., a pioneer and global leader in cell-free DNA testing, announced that the second largest commercial health plan in the United States has extended coverage of non-invasive prenatal tests to all singleton pregnancies.

Oscar, the first health insurance company built around a full stack technology platform and a relentless focus on serving our members, today announced it has hired R. Scott Blackley as its new Chief Financial Officer, effective March 16, 2021.

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community on Tuesday, Dec. 8, at 4:00 p.m. ET following the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition. David M. Reese, M.D., executive vice president of Research and Development at Amgen

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that it will host a research and development call on the Company’s systemic complement regulator programs on Monday, December 14, 2020 at 12:00 pm Eastern Time.

Johnson & Johnson announced that Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General has been appointed to its Board of Directors.

The Lupus Research Alliance is proud to announce the 2020 recipients of its Lupus Mechanisms and Targets Award (LMTA).

Combination Offers Customers Access to Largest U.S. Oncology Real World Data Source and Best-in-Class Product Development Expertise for Faster, Smarter and More Patient-Centric Clinical Trials